Inhaled Nitrous Oxide for Treatment-Resistant Depression: Optimizing Dosing Strategies

PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

November 22, 2016

Primary Completion Date

February 18, 2020

Study Completion Date

February 18, 2020

Conditions
Depressive Disorder, MajorDepressive Disorder, Treatment-Resistant
Interventions
DRUG

Nitrous Oxide 25%

Nitrous oxide, an odorless, colorless gas typically used as an induction agent for general anesthesia or for dental sedation, is a known N-methyl-D-aspartate (NMDA) antagonist. It will be given at a concentration of 25% nitrous oxide/50% oxygen/25% nitrogen.

DRUG

Nitrous Oxide 50%

Nitrous oxide, an odorless, colorless gas typically used as an induction agent for general anesthesia or for dental sedation, is a known N-methyl-D-aspartate (NMDA) antagonist. It will be given at a concentration of 50% nitrous oxide/50% oxygen.

DRUG

Placebo Gas

Placebo gas given at 50% nitrogen \[inert\]/50% oxygen.

Trial Locations (1)

63110

Washington University School of Medicine, St Louis

Sponsors
All Listed Sponsors
collaborator

Brain & Behavior Research Foundation

OTHER

lead

Washington University School of Medicine

OTHER